Niruja Product Development And Healthcare Research Private Limited, a active private limited company, was established on 13 December 2007 in Bangalore, Karnataka, India. Engaging in oncology clinics & cancer treatment within the hospital and medical care sector, it holds CIN: U73100KA2007PTC044658. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹4.80 Cr and a paid-up capital of ₹4.80 Cr.
Formerly known as Mims Hcg Oncology Private Limited. It upholds a compliant status. Its leadership includes Ramesh S Bilimagga (Director), Manish Mattoo (Additional Director). Past directors included Abdulla Cherayakkat, Anant Shrinivas Kittur, Ramesh S Bilimagga. Its latest AGM occurred on 25 September 2024, with the balance sheet filed on 31 March 2024. It is based at Hcg Tower, No.8. P.Kalinga Rao Road Sampangi Rama Nagar,, Bangalore, Karnataka, 560027.
U73100KA2007PTC044658
044658
13 December 2007
₹4.80 Cr
₹4.80 Cr
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Niruja Product Development And Healthcare Research Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ramesh S Bilimagga | Director | 30 Mar 2015 | Current |
| Manish Mattoo | Additional Director | 30 Jun 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 17 Jan 2011 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2016 | Past |
| Pramod Abcsdd | Additional Director | 22 Sep 2015 | Past |
| Pramod Abcsdd | Director | 28 Sep 2017 | Past |
| Pramod Abcsdd | Additional Director | 30 Nov 2021 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2011 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Niruja Product Development And Healthcare Research Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 17.12%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
In 2023, Niruja Product Development And Healthcare Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Niruja Product Development And Healthcare Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Niruja Product Development And Healthcare Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Niruja Product Development And Healthcare Research's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Manish Mattoo was appointed as a Additional Director was appointed as a Additional Director on 30 Jun 2025 & has been associated with this company since 5 months 23 days . was completed.
The activity Niruja Product Development And Healthcare Research Private Limited last Annual general meeting of members was held on 25 Sep 2024 as per latest MCA records. was completed.
Niruja Product Development And Healthcare Research Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was recorded as a recent event.
Progress on Ramesh S Bilimagga was appointed as a Director was appointed as a Director on 30 Mar 2015 & has been associated with this company since 10 years 8 months . was documented.
Progress on Niruja Product Development And Healthcare Research Private Limited was registered on 13 Dec 2007 with Roc Bangalore & aged 18 years 9 days as per MCA records. was documented.
The CIN of Niruja Product Development And Healthcare Research Private Limited is U73100KA2007PTC044658.
Niruja Product Development And Healthcare Research Private Limited is headquartered at Hcg Tower, No.8. P.Kalinga Rao Road Sampangi Rama Nagar,, Bangalore, Karnataka, 560027.
Niruja Product Development And Healthcare Research Private Limited was incorporated on 13 December 2007.
The current directors of Niruja Product Development And Healthcare Research Private Limited are
The primary industry of Niruja Product Development And Healthcare Research Private Limited is Hospital And Medical Care.
Niruja Product Development And Healthcare Research Private Limited is unlisted.
The authorized capital of Niruja Product Development And Healthcare Research Private Limited is ₹4.80 Cr, and the paid-up capital is ₹4.80 Cr.
The compliance status of Niruja Product Development And Healthcare Research Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX